PHGUF OTC
Pharming Group N.V.
1W: +0.0%
1M: +0.9%
3M: -14.6%
YTD: -32.7%
1Y: -26.0%
3Y: -11.2%
5Y: -15.3%
$1.10
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$44M
+2563.6% ▲
5Y CAGR: -13.4%
Capital Expenditures
$663K
+12.3% ▲
5Y CAGR: -47.4%
Free Cash Flow
$44M
+747.9% ▲
5Y CAGR: -10.2%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$78M
+1241.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $22M | $15M | -$10M | -$8M | $3M |
| Depreciation & Amort. | $19M | $13M | $16M | $16M | $10M |
| Stock-Based Comp. | $9M | $6M | $9M | $11M | $0 |
| Change in Working Capital | -$5M | -$387K | -$17M | -$10M | $13M |
| Other Non-Cash Items | -$8M | -$11M | -$16M | -$11M | $19M |
| Operating Cash Flow | $36M | $23M | -$17M | -$2M | $44M |
| — Investing Activities — | |||||
| Capital Expenditures | -$16M | -$2M | -$1M | -$762K | -$669K |
| Acquisitions (Net) | $0 | $7M | $0 | $0 | -$58M |
| Investment Purchases | -$4M | $0 | -$382M | -$284M | -$656K |
| Investment Sales | $0 | $0 | $233M | $317M | $75M |
| Other Investing | -$0 | $6M | $21M | -$34K | -$889 |
| Investing Cash Flow | -$20M | $5M | -$129M | $32M | $16M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3M | -$3M | -$5M | -$34M | -$4M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$30M | -$4M | $4M | -$5M | -$516K |
| Financing Cash Flow | -$27M | -$5M | -$941K | -$34M | $13M |
| Net Change in Cash | $3M | $15M | -$146M | -$7M | $78M |
| Cash End of Period | $192M | $207M | $62M | $55M | $124M |
| Free Cash Flow | $20M | $21M | -$19M | -$7M | $44M |